BioNTech SE (BNTX)
USD 111.61
(-4.92%)
USD 111.61
(-4.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.81 Billion | 17.31 Billion | 18.97 Billion | 482.32 Million | 108.58 Million | 127.57 Million |
| Cost of Revenue | 599.8 Million | 4.53 Billion | 3.86 Billion | 704.36 Million | 243.82 Million | 156.73 Million |
| Gross Profit | 3.21 Billion | 12.77 Billion | 15.11 Billion | -222.03 Million | -135.23 Million | -29.15 Million |
| Operating Expenses | 2.52 Billion | 135.9 Million | 200.1 Million | -139.62 Million | 46.28 Million | 24.69 Million |
| Selling, General and Administrative Expenses | 557.7 Million | 544.2 Million | 328.9 Million | 108.56 Million | 43.41 Million | 27.09 Million |
| Research and Development Expenses | 1.78 Billion | 116 Million | 102.7 Million | 645.02 Million | 226.46 Million | 143.04 Million |
| Other Expenses | 188 Million | -524.3 Million | -128.8 Million | -893.21 Million | -223.59 Million | - |
| Cost and Expenses | 3.12 Billion | 4.66 Billion | 4.06 Billion | 564.74 Million | 290.1 Million | 181.42 Million |
| Operating Income | 690.4 Million | 12.64 Billion | 15.28 Billion | -82.41 Million | -181.51 Million | -53.85 Million |
| Interest Expense | 7.9 Million | 18.9 Million | 5.4 Million | 64.94 Million | 1.71 Million | 1.72 Million |
| Income Tax Expense | 255.8 Million | 3.51 Billion | 4.75 Billion | -161 Million | -268 Thousand | 600 Thousand |
| Earnings before Tax | 1.18 Billion | 12.95 Billion | 15.04 Billion | -145.8 Million | -179.44 Million | -47.66 Million |
| Net Income | 930.3 Million | 9.43 Billion | 10.29 Billion | 15.2 Million | -179.17 Million | -48.01 Million |
| Earnings Per Share Basic | 3.83 | 38.08 | 43.87 | 0.06 | -0.85 | -0.21 |
| Earnings Per Share Diluted | 3.83 | 37.09 | 41.21 | 0.06 | -0.85 | -0.21 |
| Weighted Average Shares Outstanding | 242.89 Million | 243.3 Million | 244 Million | 235.44 Million | 211.49 Million | 226.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 242.7 Million | 249.8 Million | 259.7 Million | 248.52 Million | 211.49 Million | 226.85 Million |
| Gross Margin | 0.84 | 0.74 | 0.80 | -0.46 | -1.25 | -0.23 |
| EBIT Margin | 0.28 | 0.76 | 0.79 | -0.09 | -1.35 | -0.24 |
| Profit Margin | 0.24 | 0.55 | 0.54 | 0.03 | -1.65 | -0.38 |
| EBITDA | 1.08 Billion | 12.42 Billion | 15 Billion | -105.1 Million | -152.3 Million | -30 Million |
| Earnings Before Tax Margin | 0.18 | 0.73 | 0.81 | -0.17 | -1.67 | -0.42 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 129.35 Million | 187.6 Million | 3.81 Billion | 1.47 Billion | 895.3 Million | 167.7 Million |
| Cost of Revenue | 60.1 Million | 59.1 Million | 599.8 Million | 179.1 Million | 659.7 Million | 536.3 Million |
| Gross Profit | 69.24 Million | 128.5 Million | 3.21 Billion | 1.29 Billion | 235.6 Million | -368.6 Million |
| Operating Expenses | 772.28 Million | 635.7 Million | 2.31 Billion | 701.9 Million | 153.7 Million | 194.7 Million |
| Selling, General and Administrative Expenses | 184.72 Million | 132.6 Million | - | 149.4 Million | 150.8 Million | 140.8 Million |
| Research and Development Expenses | 587.55 Million | 507.5 Million | - | 577.8 Million | 512.38 Million | 372.57 Million |
| Other Expenses | 266.69 Million | - | - | - | - | - |
| Cost and Expenses | 832.38 Million | 694.8 Million | 2.91 Billion | 881 Million | 813.4 Million | 731 Million |
| Operating Income | -703.03 Million | -507.2 Million | 690.4 Million | 526.2 Million | 73.1 Million | -563.3 Million |
| Interest Expense | 7.3 Million | 4.7 Million | 7.73 Million | 18.9 Million | 2 Million | 1.3 Million |
| Income Tax Expense | 2.01 Million | -16.7 Million | 255.8 Million | 205.3 Million | 66.8 Million | -221.8 Million |
| Earnings before Tax | -809.87 Million | -331.8 Million | 1.18 Billion | 663.2 Million | 227.4 Million | -412.2 Million |
| Net Income | -811.88 Million | -315.1 Million | 930.3 Million | 457.9 Million | 160.6 Million | -190.4 Million |
| Earnings Per Share Basic | -3.42 | -1.31 | - | 1.88 | 0.69 | -0.79 |
| Earnings Per Share Diluted | -3.42 | -1.31 | - | 1.84 | 0.69 | -0.79 |
| Weighted Average Shares Outstanding | 237.72 Million | 240.53 Million | 240.6 Million | 237.72 Million | 239.7 Million | 239.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 237.72 Million | 240.53 Million | 242.7 Million | 241.87 Million | 239.7 Million | 239.77 Million |
| Gross Margin | 0.54 | 0.68 | 0.84 | 0.88 | 0.26 | -2.20 |
| EBIT Margin | -5.05 | -1.54 | - | 0.34 | 0.24 | -2.26 |
| Profit Margin | -6.28 | -1.68 | 0.24 | 0.31 | 0.18 | -1.14 |
| EBITDA | -652.88 Million | -288.8 Million | - | 507.4 Million | 215.7 Million | -379 Million |
| Earnings Before Tax Margin | -5.44 | -2.70 | 0.18 | 0.36 | 0.08 | -3.36 |
BW
ISHI
CHEM
MTU
SSP
BNKR